We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$42.7B
AUM Growth
-$2.16B
(-4.8%)
Cap. Flow
-$4.55B
Cap. Flow
% of AUM
-10.67%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,600
New
186
Increased
692
Reduced
1,373
Closed
340
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$408M |
| 2 |
Broadcom
AVGO
|
+$322M |
| 3 |
Merck
MRK
|
+$310M |
| 4 |
Wells Fargo
WFC
|
+$296M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$556M |
| 2 |
Amazon
AMZN
|
+$547M |
| 3 |
Netflix
NFLX
|
+$361M |
| 4 |
Advanced Micro Devices
AMD
|
+$351M |
| 5 |
PayPal
PYPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.32% |
| 3 | Financials | 14.97% |
| 4 | Consumer Discretionary | 11.06% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLVX
2226
DELISTED
HilleVax
HLVX
| $41K | ﹤0.01% |
23,300
+7,200
| +45% | +$18.5K |
|
|
ALLK
2227
DELISTED
Allakos
ALLK
| $40.8K | ﹤0.01% |
62,500
+27,400
| +78% | +$19.8K |
|
|
AEVA
2228
Aeva Technologies
AEVA
$965M
| $39.3K | ﹤0.01% |
11,940
-2,020
| -14% | -$6.05K |
|
|
TIXT
2229
DELISTED
TELUS International
TIXT
| $39.1K | ﹤0.01% |
10,000
-71,400
| -88% | -$321K |
|
2230
Traeger
COOK
$161M
| $39K | ﹤0.01% |
212
-216
| -50% | -$32K |
|
2231
Ceragon Networks
CRNT
$195M
| $38.9K | ﹤0.01% |
14,200
+1,800
| +15% | +$4.92K |
|
2232
Vor Biopharma
VOR
$1.06B
| $35.2K | ﹤0.01% |
+2,515
| New | +$45.8K |
|
|
MRNS
2233
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $34.7K | ﹤0.01% |
19,725
-22,900
| -54% | -$32K |
|
2234
RLX Technology
RLX
$2.43B
| $34.6K | ﹤0.01% |
+19,100
| New | +$32.8K |
|
|
ELEV
2235
DELISTED
Elevation Oncology
ELEV
| $34.3K | ﹤0.01% |
+57,100
| New | +$84.7K |
|
2236
Compugen
CGEN
$213M
| $33.5K | ﹤0.01% |
+18,484
| New | +$33.7K |
|
|
CMRX
2237
DELISTED
Chimerix, Inc.
CMRX
| $30.2K | ﹤0.01% |
32,500
-300
| -0.9% | -$268 |
|
|
RERE
2238
ATRenew
RERE
$950M
| $30K | ﹤0.01% |
10,800
-1,500
| -12% | -$3.65K |
|
|
NOTV
2239
DELISTED
Inotiv
NOTV
| $29.1K | ﹤0.01% |
17,100
-64,600
| -79% | -$109K |
|
2240
Sentage Holdings
SNTG
$5.41M
| $28.2K | ﹤0.01% |
+12,098
| New | +$27K |
|
2241
Standard BioTools
LAB
$308M
| $26.7K | ﹤0.01% |
13,832
-24,600
| -64% | -$48.2K |
|
2242
Babcock & Wilcox
BW
$1.3B
| $26.4K | ﹤0.01% |
12,934
-69,400
| -84% | -$98.6K |
|
|
MYSE
2243
Myseum.AI Inc
MYSE
$12.3M
| $26.1K | ﹤0.01% |
+20,100
| New | +$27.2K |
|
2244
Karyopharm Therapeutics
KPTI
$159M
| $25.9K | ﹤0.01% |
+2,080
| New | +$25.8K |
|
|
RJET
2245
Republic Airways Holdings
RJET
$852M
| $25.7K | ﹤0.01% |
1,413
-307
| -18% | -$6.32K |
|
2246
Village Farms International
VFF
$246M
| $24.7K | ﹤0.01% |
26,600
-41,000
| -61% | -$41.9K |
|
2247
Quantum-Si Incorporated
QSI
$166M
| $24.3K | ﹤0.01% |
27,500
-3,200
| -10% | -$3.11K |
|
|
ACHL
2248
DELISTED
Achilles Therapeutics
ACHL
| $22.8K | ﹤0.01% |
22,400
-1,100
| -5% | -$881 |
|
2249
Ampco-Pittsburgh
AP
$170M
| $22.6K | ﹤0.01% |
+11,300
| New | +$18.9K |
|
2250
Invivyd
IVVD
$175M
| $22.5K | ﹤0.01% |
22,100
-22,300
| -50% | -$24.2K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, Two Sigma Advisers held 2,600 positions worth $42.7B, down 4.8% from $44.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Two Sigma Advisers withdrew a net $4.55B in Q3 2024, closing 340 positions and reducing 1,373 holdings. Its most notable exit was Advanced Micro Devices, an estimated $351M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Two Sigma Advisers opened a new position in Amphenol worth $114M.
- Two Sigma Advisers's largest Q3 2024 buy was Amphenol: 1,746,900 shares worth $114M.
- Two Sigma Advisers added most to Bank of America in Q3 2024, an estimated $408M increase.
- Two Sigma Advisers's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $556M.
- Two Sigma Advisers fully exited Advanced Micro Devices in Q3 2024, selling an estimated $351M.
- Two Sigma Advisers's ten largest holdings make up 17% of its $42.7B portfolio in Q3 2024.
- Two Sigma Advisers opened 186 new positions and closed 340 in Q3 2024.
- Two Sigma Advisers's portfolio value fell 4.8% quarter-over-quarter to $42.7B.
Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.